Chi-Hong Tseng1 article listing Chi-Hong Tseng in Nature Communications, indexed by Paperzzz from Crossref and OSF.Neoadjuvant modified FOLFIRINOX plus nivolumab in borderline-resectable pancreatic ductal adenocarcinoma: a pilot phase 1 trial Nature Communications